Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Inventory Average (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Inventory Average for 10 consecutive years, with $203.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 73.73% year-over-year to $203.4 million, compared with a TTM value of $203.4 million through Dec 2025, up 73.73%, and an annual FY2025 reading of $173.8 million, up 94.76% over the prior year.
  • Inventory Average was $203.4 million for Q4 2025 at Amicus Therapeutics, up from $166.4 million in the prior quarter.
  • Across five years, Inventory Average topped out at $203.4 million in Q4 2025 and bottomed at $17.1 million in Q3 2022.
  • Average Inventory Average over 5 years is $66.7 million, with a median of $46.7 million recorded in 2023.
  • The sharpest move saw Inventory Average dropped 26.01% in 2022, then skyrocketed 217.17% in 2023.
  • Year by year, Inventory Average stood at $24.4 million in 2021, then decreased by 24.14% to $18.5 million in 2022, then surged by 214.47% to $58.3 million in 2023, then skyrocketed by 100.73% to $117.1 million in 2024, then surged by 73.73% to $203.4 million in 2025.
  • Business Quant data shows Inventory Average for FOLD at $203.4 million in Q4 2025, $166.4 million in Q3 2025, and $143.6 million in Q2 2025.